Summary
Partner Kris Bieker was the chairperson of the "Microbiome Therapeutics US" conference as part of Biotech Week Boston in Boston, MA.
Speakers
- /en/people/b/bieker-kristina
Kristina Bieker
Partner
Related Content
- Big Molecule WatchAugust 29, 2024
FTC Comment on FDA Draft Guidance on Interchangeability
- Big Molecule WatchAugust 28, 2024
Del. Judge Connolly Says Preambles Are Limiting, Cites Alice in Wonderland, and Invites the Federal Circuit to Weigh In
- Big Molecule WatchAugust 26, 2024
EMA Accepts Marketing Authorization Application for Alvotech’s AVT06 (aflibercept)
- Big Molecule WatchAugust 22, 2024
Proposed BPCIA Reform Legislation Likely To Have Little Effect Even If Passed
- Big Molecule WatchAugust 20, 2024
FDA Seeks Input on Biosimilar Product Development Guidance
- Big Molecule WatchAugust 15, 2024
Genzyme Sues Sarepta for Infringement of Gene Therapy Patents
- Big Molecule WatchAugust 15, 2024
Recent PTAB Developments for Regeneron’s Aflibercept-Dosing Patents
- Life Sciences PerspectivesAugust 14, 2024
FDA Platform Technology Draft Guidance Highlights Utility of Obscure Patent Term Extension Provision
- In the PressAugust 27, 2024
Deal Watch: Taking the Lead in PE Activity, Goodwin Top First Half League Tables (The American Lawyer)
- Awards and RankingsAugust 23, 2024
Goodwin is Top Law Firm for M&A and Private Equity
- Awards and RankingsAugust 15, 2024
The Best Lawyers in America 2025 Recognizes 312 Goodwin Lawyers
- In the PressAugust 13, 2024
Test-Makers See Way Out Of FDA Rule With Chevron Reversal (Law360)
- Awards and RankingsAugust 7, 2024
Benchmark Litigation Names Fourteen Goodwin Partners to 40 & Under Hot List 2024
- Press ReleaseAugust 2, 2024
Spear Bio Completes $45 Million Series A
- Awards and RankingsAugust 1, 2024
Philadelphia Business Journal Names Laura Umbrecht Gulick a Woman of Influence for 2024
- Speaking EngagementsJuly 31, 2024 | 2:00 PM - 3:15 PM ET
ACS Webinar - Avoiding IP Own Goals in Drug Discovery: Best Practices for Obtaining (and Keeping) Your IP